GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Total Long-Term Liabilities

Laurus Labs (BOM:540222) Total Long-Term Liabilities : ₹11,933 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Laurus Labs's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹11,933 Mil.

Laurus Labs Total Long-Term Liabilities Historical Data

The historical data trend for Laurus Labs's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Total Long-Term Liabilities Chart

Laurus Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,928.40 9,279.80 11,794.80 11,591.80 11,933.30

Laurus Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,591.80 - 11,256.60 - 11,933.30

Laurus Labs Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Laurus Labs Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Laurus Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:532331 BOM:543635 BOM:524494 BOM:506943 NSE:GLAND BOM:544210 BOM:532296 BOM:543064 BOM:532300 BOM:540596 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
LAURUSLABS:India
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Website
https://www.lauruslabs.com
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs Headlines

No Headlines